What Ozempic is and how it works
Ozempic is brand name for semaglutide manufactured by Novo Nordisk. It acts as GLP-1 receptor agonist mimicking natural glucagon-like peptide-1 hormone. The once-weekly injection slows gastric emptying, reduces appetite, increases satiety and improves blood sugar regulation. In the UK, Ozempic is licensed only for type 2 diabetes treatment - not for weight management. Wegovy is the same molecule (semaglutide) at higher doses licensed specifically for weight management. Ozempic became popular for off-label weight loss use causing shortages affecting diabetes patients. The UK medicines regulator (MHRA) has guidance on off-label use. Adults seeking semaglutide for weight loss should obtain Wegovy through proper prescribing channels rather than Ozempic off-label.
Ozempic explained
Ozempic represents specific medication with specific licensed uses in UK. Understanding what it is and isn't helps make informed decisions.
Semaglutide is the active ingredient
Ozempic is brand name for semaglutide manufactured by Novo Nordisk. Same molecule available in different brand names for different purposes: Ozempic and Rybelsus for diabetes, Wegovy for weight management. The active ingredient is identical though doses differ.
GLP-1 receptor agonist
Ozempic activates GLP-1 receptors mimicking natural glucagon-like peptide-1 hormone. The mechanism affects appetite, satiety, gastric emptying and blood sugar regulation. Older mechanism than dual agonists like Mounjaro but still effective.
Licensed only for diabetes in UK
Ozempic licensed by MHRA for type 2 diabetes treatment specifically. Not licensed for weight management in UK. The licensing matters for prescribing legitimacy. Off-label prescribing exists but Wegovy (same molecule, different brand) licensed for weight loss specifically.
Wegovy is semaglutide for weight loss
Wegovy contains same semaglutide molecule as Ozempic but at higher doses licensed for weight management. Adults seeking semaglutide for weight loss should obtain Wegovy through proper channels rather than Ozempic off-label. The distinction matters.
Caused shortages affecting diabetes patients
Off-label use of Ozempic for weight loss caused shortages affecting diabetes patients who needed it for diabetes control. The supply chain issues led to UK and global concerns. Using Wegovy for weight loss helps preserve Ozempic for licensed diabetes use.
Practical approach
Adults considering semaglutide for weight loss can approach decision through specific considerations.
Consult GP about Wegovy specifically
Wegovy is semaglutide licensed for weight management. Discuss eligibility, prescribing options and cost with GP or specialist clinic. The medical involvement essential.
Don't seek Ozempic off-label
Ozempic for weight loss not licensed use in UK. The off-label use caused shortages affecting diabetes patients. Wegovy provides proper option for semaglutide weight management treatment.
Understand eligibility for Wegovy
NICE criteria for Wegovy include BMI 35 plus with comorbidity or BMI 30 plus with specific conditions. Adults not meeting criteria may need to consider other approaches. The criteria define legitimate prescribing.
Plan for cost
Wegovy privately costs 150 to 300 pounds monthly typically. NHS prescription possible for adults meeting criteria but access limited. The cost matters substantially. Calculate over months and years.
Combine with lifestyle changes
Semaglutide works better with dietary changes and exercise. Adults relying solely on medication without lifestyle changes experience less weight loss. The combination produces best outcomes.
Important safety information
Semaglutide is prescription medication requiring medical supervision. The following points warrant attention.
- Only through legitimate prescription. Online unregulated sources have significant counterfeit risks.
- Wegovy is licensed weight loss product. Don't seek Ozempic off-label - use proper channels.
- Common side effects affect most users. Nausea, GI issues especially during dose escalation.
- Not suitable during pregnancy or breastfeeding. Stop before pregnancy planning.
- Medical supervision essential. Regular monitoring for side effects and effectiveness.
Ozempic is brand name for semaglutide licensed only for type 2 diabetes in UK. Wegovy is same molecule at higher doses licensed specifically for weight management. GLP-1 receptor agonist slowing gastric emptying, reducing appetite, improving blood sugar regulation. Adults seeking semaglutide for weight loss should obtain Wegovy through proper prescribing channels rather than Ozempic off-label. Off-label use caused shortages affecting diabetes patients. Consult GP about Wegovy specifically. Understand eligibility criteria. Plan for cost. Combine with lifestyle changes. This article is informational - specific medical decisions should be made with your GP or specialist who can assess your individual situation.
For more on weight loss medications our Weight Loss Hub brings every guide together.
Back to the Weight Loss Hub
This article sits inside our complete weight loss knowledge base covering calorie management, nutrition, exercise, behaviour change, GLP-1 medications, plateaus, maintenance and the practical guidance behind sustainable weight loss. Head back to the hub for the full index.
More on weight loss medications
Ozempic connects to related topics. what Mounjaro is and how it works covers Mounjaro. Mounjaro vs Ozempic clinical differences covers comparison. And prescribing rules UK covers prescribing.


Share:
What Mounjaro Is and How It Works
Mounjaro vs Ozempic: Clinical Differences Explained